NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/11/2025
Back to search
Official data from USPTO
C.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
03/11/2025
Classification
Registered
Trademark type
Combined
Nice classes
5, 42
Filing date
03/07/2022
Registration date
03/11/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/11/2025
Last transaction
03/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/05/2023
First use in commerce
06/05/2023
Drawing code
3
Owner type
03
Owner location
South San Francisco, CA, US
Examiner
ALTREE, NICK
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of stylized "C" with a circle between the opening.
Holders and representatives
Holders
Cytokinetics, Incorporated
Representatives
B. Brett Heavner FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
human pharmaceuticals for the treatment of cardiovascular diseases, diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness
Class 42
research in the field of cellular assay screening and pharmaceutical discovery and development
Publications
History of USPTO decisions and trademark events.
39 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/11/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/20/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/20/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/20/2025
ALIE
ASSIGNED TO LIE
02/20/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/23/2024
GNRT
NON-FINAL ACTION E-MAILED
11/23/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/23/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/22/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
11/22/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/24/2024
IUAF
USE AMENDMENT FILED
08/20/2024
DRRR
DIVISIONAL REQUEST RECEIVED
08/20/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
08/20/2024
EISU
TEAS STATEMENT OF USE RECEIVED
08/20/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/20/2024
EX3G
SOU EXTENSION 3 GRANTED
08/20/2024
EXT3
SOU EXTENSION 3 FILED
08/20/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/20/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/13/2024
EX2G
SOU EXTENSION 2 GRANTED
03/12/2024
EXT2
SOU EXTENSION 2 FILED
03/12/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/12/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/09/2023
EX1G
SOU EXTENSION 1 GRANTED
09/07/2023
EXT1
SOU EXTENSION 1 FILED
09/07/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/07/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/24/2023
PUBO
PUBLISHED FOR OPPOSITION
01/24/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2022
DOCK
ASSIGNED TO EXAMINER
12/17/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2022
NWAP
NEW APPLICATION ENTERED
03/10/2022
Continuous trademark protection
Get notified about every new filing that threatens C. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.